Clinical trial
Effects of Neoadjuvant Immunotherapy on Patients With Lung Cancer: a Prospective, Observational Study
NCT07166003 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Neoadjuvant Immunotherapy on Patients With Lung Cancer: a Prospective, Observational Study
- Lead sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 20, 2025
- Completion date
- April 14, 2030
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
immunotherapy, lung cancer, non-small cell